Abstract Learning Objectives After completing this course, the reader will be able to: Assess
patients with EBV-associated lymphoproliferative disorders. Describe the pathogenesis of …

Hypertension in kidney transplant recipients is a major “traditional” risk factor for
atherosclerotic cardiovascular disease. Importantly, atherosclerotic cardiovascular disease …

Abstract Introduction Coronavirus disease 2019 (COVID‐19) has rapidly become a global
pandemic, but little is known about its potential impact on patients with myasthenia gravis …

Oral ganciclovir prophylaxis and intravenous preemptive therapy are competitive
approaches to prevent cytomegalovirus (CMV) disease after renal transplantation. This trial …

Cancer incidence is increased in renal transplant recipients due to immunosuppressant
treatment that should be maintained to prevent and treat acute rejection. Use of new and …

Modern immunosuppressive regimens reduce the acute rejection rate by combining a
cornerstone immunosuppressant like tacrolimus or cyclosporine with adjunctive agents like …

Background Hepatotoxicity results in the withdrawal of thiopurines drugs, azathioprine (AZA)
and mercaptopurine (MP), in up to 10% of patients with inflammatory bowel disease. Our …

An International Conference on the Care of the Kidney Transplant Recipient was convened
in Lisbon, Portugal from February 2–4, 2006 under the auspices of the National Kidney …

Does pre-emptive transplantation versus post start of dialysis transplantation with a kidney from
a living donor improve outcomes after transplantation? A systematic literature review and …

Infective endocarditis (IE) in chronic haemodialysis (HD) is significantly more common and
causes greater morbidity and mortality than in the general population, being second only to …